Juno sets IPO terms, presents CAR T data

Juno Therapeutics Inc. (Seattle, Wash.) set terms for its IPO on NASDAQ and now plans to sell 9.25 million shares at $15-$18. At $16.50, Juno would raise $152.6 million and be valued at $1.3 billion. The company

Read the full 370 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE